Gene · 3205
Papers4,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 4,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Superenhancers as master gene regulators and novel therapeutic targets in brain tumors. | Exp Mol Med | 2023 | 36720920 | PubTator, text mining | PubMed |
| The histone demethylase JMJD2C constitutes a novel NFE2 target gene that is required for the survival of JAK2V617F mutated cells. | Leukemia | 2023 | 36709354 | PubTator, text mining | PubMed |
| Current advances in noninvasive methods for the diagnosis of oral squamous cell carcinoma: a review. | Eur J Med Res | 2023 | 36707844 | PubTator, text mining | PubMed |
| Enhancer remodeling drives MLL oncogene-dependent transcriptional dysregulation in leukemia stem cells. | Blood Adv | 2023 | 36705973 | PubTator, text mining | PubMed |
| Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma. | Cancer Discov | 2023 | 36700848 | PubTator, text mining | PubMed |
| Targeting Pim kinases in hematological cancers: molecular and clinical review. | Mol Cancer | 2023 | 36694243 | PubTator, text mining | PubMed |
| An atlas of lamina-associated chromatin across twelve human cell types reveals an intermediate chromatin subtype. | Genome Biol | 2023 | 36691074 | PubTator, text mining | PubMed |
| Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potential. | World J Gastroenterol | 2023 | 36683709 | PubTator, text mining | PubMed |
| Stemness-related genes revealed by single-cell profiling of naïve and stimulated human CD34+ cells from CB and mPB. | Clin Transl Med | 2023 | 36683248 | PubTator, text mining | PubMed |
| Epigenetic Modification of Cytosines in Hematopoietic Differentiation and Malignant Transformation. | Int J Mol Sci | 2023 | 36675240 | PubTator, text mining | PubMed |
| Changes in Hox Gene Chromatin Organization during Odontogenic Lineage Specification. | Genes (Basel) | 2023 | 36672939 | PubTator, text mining | PubMed |
| Patient-Derived Primary Cancer-Associated Fibroblasts Mediate Resistance to Anti-Angiogenic Drug in Ovarian Cancers. | Biomedicines | 2023 | 36672620 | PubTator, text mining | PubMed |
| De Novo Generation of Human Hematopoietic Stem Cells from Pluripotent Stem Cells for Cellular Therapy. | Cells | 2023 | 36672255 | PubTator, text mining | PubMed |
| SF3B4 promotes Twist1 expression and clear cell renal cell carcinoma progression by facilitating the export of KLF 16 mRNA from the nucleus to the cytoplasm. | Cell Death Dis | 2023 | 36639679 | PubTator, text mining | PubMed |
| Metabolism in stem cell-driven leukemia: parallels between hematopoiesis and immunity. | Blood | 2023 | 36634302 | PubTator, text mining | PubMed |
| Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single-cell resolution. | Elife | 2023 | 36629404 | PubTator, text mining | PubMed |
| A retrospective assessment of real-world experience with venetoclax and azacitidine therapy in elderly acute myeloid leukemia. | Anticancer Drugs | 2023 | 36622759 | PubTator, text mining | PubMed |
| A Live Cell Protein Complementation Assay for ORFeome-Wide Probing of Human HOX Interactomes. | Cells | 2023 | 36611993 | PubTator, text mining | PubMed |
| Early response evaluation by single cell signaling profiling in acute myeloid leukemia. | Nat Commun | 2023 | 36611026 | PubTator, text mining | PubMed |
| ADAR1-dependent miR-3144-3p editing simultaneously induces MSI2 expression and suppresses SLC38A4 expression in liver cancer. | Exp Mol Med | 2023 | 36599932 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3205/papers?page=28